MiR-135 family members mediate podocyte injury through the activation of Wnt/β-catenin signaling

International Journal of Molecular Medicine

Volumn 36, Issue 3, 2015, Pages 669-677

  Yang, Xianggui ^a   Wang, Xiaoyan ^a   Nie, Fang ^a   Liu, Tianming ^a   Yu, Xuejing ^b   Wang, Honglian ^c   Li, Qianyin ^a   Peng, Rui ^a   Mao, Zhaomin ^a   Zhou, Qin ^a   Li, Ge ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Glycogen synthase kinase 3 ; Injury; MiR 135a; MiR 135b; Podocytes; Wnt catenin signaling

Indexed keywords

BETA CATENIN; DESMIN; GLYCOGEN SYNTHASE KINASE 3BETA; MICRORNA; MICRORNA 135A; MICRORNA 135B; NEPHRIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; WT1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, HUMAN; GSK3B PROTEIN, MOUSE; MIRN135 MICRORNA, HUMAN; MIRN135 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CYTOSKELETON; FOCAL GLOMERULOSCLEROSIS; GENE OVEREXPRESSION; GLOMERULOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INJURY SEVERITY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DOWN REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINE; DOWN-REGULATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HUMANS; MICE, INBRED BALB C; MICRORNAS; PODOCYTES; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84938073615     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2259     Document Type: Article

References (35)

1. Nelson WJ and Nusse R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487, 2004.
2. Teixeira VP, Blattner SM, Li M, Anders HJ, Cohen CD, Edenhofer I, Calvaresi N, Merkle M, Rastaldi MP and Kretzler M: Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 67: 514-523, 2005.
3. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB and Liu Y: Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009.
4. Cai J, Schleidt S, Pelta-Heller J, Hutchings D, Cannarsa G and Iacovitti L: BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells. Dev Biol 376: 62-73, 2013.
5. Kato H, Gruenwald A, Suh JH, Miner JH, Barisoni-Thomas L, Taketo MM, Faul C, Millar SE, Holzman LB and Susztak K: Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem 286: 26003-26015, 2011.
6. Jackson RJ and Standart N: How do microRNAs regulate gene expression? Sci STKE 2007: re1, 2007.
7. Long J, Wang Y, Wang W, Chang BH and Danesh FR: Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 285: 23457-23465, 2010.
8. Chen YQ, Wang XX, Yao XM, Zhang DL, Yang XF, Tian SF and Wang NS: MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency. Am J Nephrol 34: 549-559, 2011.
9. Wu J, Zheng C, Fan Y, Zeng C, Chen Z, Qin W, Zhang C, Zhang W, Wang X, Zhu X, et al: Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol 25: 92-104, 2014.
10. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ and Natarajan R: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104: 3432-3437, 2007.
11. Chung AC, Huang XR, Meng X and Lan HY: miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21: 1317-1325, 2010.
12. Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P and Bottinger EP: Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 19: 2159-2169, 2008.
13. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R: Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68: 5795-5802, 2008.
14. Holleman A, Chung I, Olsen RR, Kwak B, Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE and Zetter BR: miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene 30: 4386-4398, 2011.
15. Zhou W, Li X, Liu F, Xiao Z, He M, Shen S and Liu S: MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys Sin (Shanghai) 44: 838-846, 2012.
16. Yamada Y, Hidaka H, Seki N, Yoshino H, Yamasaki T, Itesako T, Nakagawa M and Enokida H: Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci 104: 304-312, 2013.
17. Wu S, Lin Y, Xu D, Chen J, Shu M, Zhou Y, Zhu W, Su X, Zhou Y, Qiu P, et al and Yan G: MiR-135a functions as a selective killer of malignant glioma. Oncogene 31: 3866-3874, 2012.
18. Anderegg A, Lin HP, Chen JA, Caronia-Brown G, Cherepanova N, Yun B, Joksimovic M, Rock J, Harfe BD, Johnson R and Awatramani R: An Lmx1b-miR135a2 regulatory circuit modulates Wnt1/Wnt signaling and determines the size of the midbrain dopaminergic progenitor pool. PLoS Genet 9: e1003973, 2013.
19. He F, Peng F, Xia X, Zhao C, Luo Q, Guan W, Li Z, Yu X and Huang F: MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 57: 1726-1736, 2014.
20. Fogo AB: Animal models of FSGS: Lessons for pathogenesis and treatment. Semin Nephrol 23: 161-171, 2003.
21. Wang Y, Wang YP, Tay YC and Harris DC: Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int 58: 1797-1804, 2000.
22. Ni L, Saleem M and Mathieson PW: Podocyte culture: Tricks of the trade. Nephrology (Carlton) 17: 525-531, 2012.
23. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W and Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997.
24. Kolfschoten IG, van Leeuwen B, Berns K, Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM and Agami R: A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 121: 849-858, 2005.
25. Bae GU, Lee JR, Kim BG, Han JW, Leem YE, Lee HJ, Ho SM, Hahn MJ and Kang JS: Cdo interacts with APPL1 and activates Akt in myoblast differentiation. Mol Biol Cell 21: 2399-2411, 2010.
26. Bae GU, Kim BG, Lee HJ, Oh JE, Lee SJ, Zhang W, Krauss RS and Kang JS: Cdo binds Abl to promote p38alpha/beta mitogen-activated protein kinase activity and myogenic differentiation. Mol Cell Biol 29: 4130-4143, 2009.
27. Pollak MR: Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 13: 3016-3023, 2002.
28. Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, Martin DR, Liapis H, Miner JH and Chen F: Activation of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc Nephrol 21: 1657-1666, 2010.
29. Welsh GI and Saleem MA: The podocyte cytoskeleton - key to a functioning glomerulus in health and disease. Nat Rev Nephrol 8: 14-21, 2012.
30. Wang D, Dai C, Li Y and Liu Y: Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria. Kidney Int 80: 1159-1169, 2011.
31. Asanuma K: The role of podocyte injury in chronic kidney disease. Nihon Rinsho Meneki Gakkai Kaishi 38: 26-36, 2015 (In Japanese).
32. Kato H and Susztak K: Repair problems in podocytes: Wnt, Notch, and glomerulosclerosis. Semin Nephrol 32: 350-356, 2012.
33. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J and Mundel P: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938, 2008.
34. Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, et al: Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Translat Med 3: 85ra46, 2011.
35. Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K and Akiyama T: Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells 3: 395-403, 1998.